SCHLX Holdings Information

SCHLX is a mutual fund with a total of 66 individual holdings. The top holdings are Eli Lilly and Company stock at 12.70%, Johnson & Johnson at 6.32%, UnitedHealth Group at 5.51%, AbbVie at 4.97%, and Merck & Co. at 4.82%.

Total Holdings

Top 10 Percentage

49.61%

Asset Class

Equity

Fund Category

Health

Assets

260.59M

Forward PE Ratio

n/a

Breakdown by Asset Class

Top 25 Holdings

No.	Symbol	Name	% Weight	Shares
1	LLY	Eli Lilly and Company	12.70%	28,554
2	JNJ	Johnson & Johnson	6.32%	63,685
3	UNH	UnitedHealth Group Incorporated	5.51%	34,323
4	ABBV	AbbVie Inc.	4.97%	51,180
5	MRK	Merck & Co., Inc.	4.82%	95,719
6	TMO	Thermo Fisher Scientific Inc.	3.62%	16,298
7	LON: AZN	AstraZeneca PLC	3.12%	47,473
8	AMGN	Amgen Inc.	2.95%	19,793
9	NVSN.MX	Novartis AG ADR	2.95%	48,800
10	ABT	Abbott Laboratories	2.65%	64,801
11	SYK	Stryker Corporation	2.50%	19,804
12	GILD	Gilead Sciences, Inc.	2.41%	47,850
13	n/a	Dws Central Cash Management Government Fund	2.37%	6,113,897
14	VRTX	Vertex Pharmaceuticals Incorporated	2.34%	12,681
15	n/a	Roche Holding Ag	2.23%	13,200
16	MCK	McKesson Corporation	2.12%	6,400
17	DHR	Danaher Corporation	2.04%	27,038
18	ISRG	Intuitive Surgical, Inc.	2.00%	14,659
19	BMY	Bristol-Myers Squibb Company	1.77%	69,916
20	NVO	Novo Nordisk A/S	1.61%	88,210
21	MDT	Medtronic plc	1.60%	48,488
22	REGN	Regeneron Pharmaceuticals, Inc.	1.59%	5,385
23	BSX	Boston Scientific Corporation	1.55%	85,856
24	CAH	Cardinal Health, Inc.	1.41%	15,800
25	COR	Cencora, Inc.	1.30%	10,814

Showing 25 of 66 holdings

Subscribe to see the full list

Activate Now

As of Jul 31, 2026